4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 900.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,500.00
  • 52 Week Low: 870.60
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 4,412
  • Market Cap: £139.85m
  • Beta: 0.03

Latest Deals

Traded Action Notifier PriceAmountValue
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,117,688 £10,059,192
Amy Walker 44,016 £396,144
Maria Del Pilar de la Huerta 6,667 £60,003
Hansjörg Plaggemars 6,667 £60,003

Major Shareholders

Notifier** Holding Value*
Wilhelm K. T. Zours 5,119,743 £46,077,687
DELPHI Unternehmensberatung AG 5,119,743 £46,077,687
4bb AG 5,115,852 £46,042,668
M&G Plc 4,627,741 £41,649,669
Elevage Medical Technologies Holdings 4,627,741 £41,649,669
Deutsche Balaton AG 4,432,637 £39,893,733
2invest AG 2,229,083 £20,061,747
Sparta AG 1,351,718 £12,165,462
Latonba AG 778,891 £7,010,019
Franciscus De Busschere 537,255 £4,835,295

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 900.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,500.00
52 Week Low 870.60
Volume 4,412
Shares Issued 15.54m
Market Cap £139.85m
Beta 0.03

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.51% below the market average65.51% below the market average65.51% below the market average65.51% below the market average65.51% below the market average
11.63% above the sector average11.63% above the sector average11.63% above the sector average11.63% above the sector average11.63% above the sector average
Price Trend
33.03% below the market average33.03% below the market average33.03% below the market average33.03% below the market average33.03% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
Income Not Available
Growth
59.18% above the market average59.18% above the market average59.18% above the market average59.18% above the market average59.18% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

4basebio Dividends

No dividends found

Trades for 15-Aug-2025

Time Volume / Share Price
12:03 32 @ 900.00p
09:51 2,150 @ 900.00p
09:51 2,150 @ 900.00p
09:53 80 @ 870.60p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page